Análisis de la acción Elevance Health Inc (ELV)ELVElevance Health Inc

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

Elevance Health Inc is a strong buy at the current price of $428.26, supported by a forward P/E ratio of 13.68, indicating potential for growth compared to its earnings. The RSI is at 82.08, suggesting the stock is currently overbought, but this momentum can continue in the short term. The company has shown a robust year-to-date change of +20.89%, reflecting strong performance. However, a risk to consider is the hedge fund selling activity, which has increased by 135.25% over the last quarter, indicating some caution among institutional investors.